PBRM1 loss defines a nonimmunogenic tumor phenotype associated with checkpoint inhibitor resistance in renal carcinoma

por Liu, Xian-De, Kong, Wen, Peterson, Christine B., McGrail, Daniel J., Hoang, Anh, Zhang, Xuesong, Lam, Truong, Pilie, Patrick G., Zhu, Haifeng, Beckermann, Kathryn E., Haake, Scott M., Isgandrova, Sevinj, Martinez-Moczygemba, Margarita, Sahni, Nidhi, Tannir, Nizar M., Lin, Shiaw-Yih, Rathmell, W. Kimryn, Jonasch, Eric
Publicado 2020